INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL
Jaeger, U., Tam, C., Borchmann, P., McGuirk, J., Holte, H., Waller, E., Jaglowski, S., Andreadis, C., Foley, S.R., Fleury, I., Westin, J., Teshima, T., Mielke, S., Salles, G., Ho, P.J., Izutsu, K., ScVolume:
37
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.189_2631
Date:
June, 2019
File:
PDF, 313 KB
english, 2019